Myricatomentoside II

Metabolite details

Identifier

BSILZSYJTIBPFN-CNFGNZGNSA-N

InChI Key

BSILZSYJTIBPFN-CNFGNZGNSA-N

IUPAC name

3,8-dihydroxy-16,17-dimethoxy-15-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxytricyclo[12.3.1.12,6]nonadeca-1(17),2,4,6(19),14(18),15-hexaen-9-one

Preferred name

Myricatomentoside II

INN name

—

Synonym

—

ChEBI

CHEBI:168711

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Metabolomic Insights into the Browning of the Peel of Bagging ‘Rui Xue’ Apple Fruit
• Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Transcriptomic dynamics control rapid transition of core crop functions in 'lactating' pigeon

Observed in differential profiles

• Non_Bagged_Fruits_vs_Bagged_Fruits_With_Browning
• Control_vs_CSD
• Control_vs_ZYP_High_Dose
• Male_19_days_vs_Male_1_day